Results
1 -
10 of
11
(Click
here to explore results)
- Separation and identification of an impurity from the istradefylline intermediate. Haojie Xu, Yiyun Wang, Hongyi Wang, Zhonghui Zheng, Zihui Meng, Min Xue, Zhibin Xu
, RSC Adv.
, 2020
, 10
, 14493
- Stabilised G protein-coupled receptors in structure-based drug design: a case study with adenosine A2A receptor. Stephen P. Andrews, Benjamin Tehan
, Med. Chem. Commun.
, 2013
, 4
, 52
- AI-based identification of therapeutic agents targeting GPCRs: introducing ligand type classifiers and systems biology. Jonas Goßen, Rui Pedro Ribeiro, Dirk Bier, Bernd Neumaier, Paolo Carloni, Alejandro Giorgetti, Giulia Rossetti
, Chem. Sci.
, 2023
, 14
, 8651
- Tricyclic xanthine derivatives containing a basic substituent: adenosine receptor affinity and drug-related properties. Michał Załuski, Katarzyna Stanuch, Tadeusz Karcz, Sonja Hinz, Gniewomir Latacz, Ewa Szymańska, Jakub Schabikowski, Agata Doroż-Płonka, Jadwiga Handzlik, Anna Drabczyńska, Christa E. Müller, Katarzyna Kieć-Kononowicz
, Med. Chem. Commun.
, 2018
, 9
, 951
- Polymeric nanoparticles for dopamine and levodopa replacement in Parkinson's disease. Obaydah Abd Alkader Alabrahim, Hassan Mohamed El-Said Azzazy
, Nanoscale Adv.
, 2022
, 4
, 5233
- An efficient route to xanthine based A
2A
adenosine receptor
antagonists and functional derivatives. Paul LaBeaume, Ma Dong, Michail Sitkovsky, Elizabeth V. Jones, Rhiannon Thomas, Sara Sadler, Amy E. Kallmerten, Graham B. Jones
, Org. Biomol. Chem.
, 2010
, 8
, 4155
- Structure-based drug design of chromone antagonists of the adenosine A2A receptor. Stephen P. Andrews, Jonathan S. Mason, Edward Hurrell, Miles Congreve
, Med. Chem. Commun.
, 2014
, 5
, 571
- New substituted 9-propyladenine derivatives as A2A
adenosine receptor antagonists. C. Lambertucci, M. Buccioni, D. Dal Ben, S. Kachler, G. Marucci, A. Spinaci, A. Thomas, K.-N. Klotz, R. Volpini
, Med. Chem. Commun.
, 2015
, 6
, 963
- Methoxy substituted 2-benzylidene-1-indanone derivatives as A1 and/or A2A AR antagonists for the potential treatment of neurological conditions. Helena D. Janse van Rensburg, Lesetja J. Legoabe, Gisella Terre'Blanche, Mietha M. Van der Walt
, Med. Chem. Commun.
, 2019
, 10
, 300
- Bitopic fluorescent antagonists of the A2A adenosine receptor based on pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine functionalized congeners. Romain Duroux, Antonella Ciancetta, Philip Mannes, Jinha Yu, Shireesha Boyapati, Elizabeth Gizewski, Said Yous, Francisco Ciruela, John A. Auchampach, Zhan-Guo Gao, Kenneth A. Jacobson
, Med. Chem. Commun.
, 2017
, 8
, 1659